日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

同源重组缺陷和半合子状态是乳腺癌耐药性的驱动因素

Safonov, Anton; Lee, Minna; Brown, David N; Boscolo Bielo, Luca; Mehine, Miika; Bandlamudi, Chaitanya; O'Leary, Ben; Shao, Hong; Vicente, Laia; Muldoon, Daniel; Zhu, Allen; Ros, Susana; Marra, Antonio; Selenica, Pier; Bieche, Ivan; Wubbenhorst, Bradley; Ferraro, Emanuela; Courtois, Laura; El Botty, Rania; Ahmed, Mehnaj; Moiso, Enrico; An, Julia Ah-Reum; Donoghue, Mark T A; Will, Marie; Pareja, Fresia; Nizialek, Emily; Lukashchuk, Natalia; Sofianopoulou, Eleni; Liu, Yuan; Huang, Xin; Chappey, Colombe; Staniszewska, Anna D; Ross, Dara; Mandelker, Diana; Ladanyi, Marc; Schultz, Nikolaus; Berger, Michael F; Scaltriti, Maurizio; Reis-Filho, Jorge S; Li, Bob T; Offit, Kenneth; Norton, Larry; Shen, Ronglai; Maxwell, Kara N; Couch, Fergus; Domchek, Susan M; Marangoni, Elisabetta; Shah, Sohrab; Albertella, Mark R; Serra, Violeta; Weigelt, Britta; Solit, David B; Nathanson, Katherine L; Robson, Mark E; Turner, Nicholas C; Chandarlapaty, Sarat; Razavi, Pedram

Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancer

通过循环肿瘤DNA分析追踪乳腺癌新辅助全身治疗的反应

Marra, Antonio; Kim, Sarah H; Pareja, Fresia; Basili, Thais; Solit, David B; Chandarlapaty, Sarat; Plitas, George; Reis-Filho, Jorge S; Weigelt, Britta; King, Tari A; Brown, David N

Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research

远程医疗与面对面知情同意在临床癌症研究中的质量比较

Sternschuss, Michal; Lattanzi, Michael; Vertosick, Emily; Austria, Mia; Martin, Sené; Regazzi, Ashley; Buckely, Michael T; Lengfellner, Joseph; Riely, Gregory J; Solit, David B; Rosenberg, Jonathan E; Iyer, Gopa; Stetson, Peter D; Morris, Michael J; Vickers, Andrew J; Funt, Samuel A

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

Clinical and genomic profiling of early-onset bladder cancer identifies key alterations and therapeutic targets

对早期膀胱癌进行临床和基因组分析,可识别关键改变和治疗靶点。

Magnani, Christopher J; D'Andrea, Vincent D; Barros, Guilherme Garcia; Qian, Zhiyu; Ernandez, John; Yim, Kendrick; Kibel, Adam S; Chang, Steven L; Mossanen, Matthew; Preston, Mark A; Feldman, Adam S; Bochner, Bernard H; Solit, David B; Pietzak, Eugene J; Mouw, Kent W; Carvalho, Filipe L F; Clinton, Timothy N

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer.

对肿瘤抑制基因双等位基因失活的泛癌分析表明,KEAP1 合子性是肺癌的预测性生物标志物

Zucker Mark, Perry Maria A, Gould Samuel I, Elkrief Arielle, Safonov Anton, Thummalapalli Rohit, Mehine Miika, Chakravarty Debyani, Brannon A Rose, Ladanyi Marc, Razavi Pedram, Donoghue Mark T A, Murciano-Goroff Yonina R, Grigoriadis Kristiana, McGranahan Nicholas, Jamal-Hanjani Mariam, Swanton Charles, Chen Yuan, Shen Ronglai, Chandarlapaty Sarat, Solit David B, Schultz Nikolaus, Berger Michael F, Chang Jason, Schoenfeld Adam J, Sánchez-Rivera Francisco J, Reznik Ed, Bandlamudi Chaitanya

Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters

Kmt2c 或 Kmt2d 的缺失会使尿路上皮细胞更容易发生肿瘤,并将 KMT2A-menin 重新分布到二价启动子。

Naitao Wang # ,Mohini R Pachai # ,Dan Li # ,Cindy J Lee ,Sarah Warda ,Makhzuna N Khudoynazarova ,Woo Hyun Cho ,Guojia Xie ,Sagar R Shah ,Li Yao ,Cheng Qian ,Elissa W P Wong ,Juan Yan ,Fanny V Tomas ,Wenhuo Hu ,Fengshen Kuo ,Sizhi P Gao ,Jiaqian Luo ,Alison E Smith ,Ming Han ,Dong Gao ,Kai Ge ,Haiyuan Yu ,Sarat Chandarlapaty ,Gopakumar V Iyer ,Jonathan E Rosenberg ,David B Solit ,Hikmat A Al-Ahmadie ,Ping Chi ,Yu Chen

Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies

基于遗传祖先的差异对基于生物标志物的精准肿瘤治疗资格的影响

Arora, Kanika; Suehnholz, Sarah P; Zhang, Hongxin; Ostrovnaya, Irina; Kundra, Ritika; Nandakumar, Subhiksha; Nissan, Moriah H; Brannon, A Rose; Bandlamudi, Chaitanya; Ladanyi, Marc; Drilon, Alexander; Brown, Carol L; Solit, David B; Schultz, Nikolaus; Berger, Michael F; Chakravarty, Debyani

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

尿路上皮癌对HER2靶向抗体药物偶联物敏感性的决定因素

Chen, Ziyu; Tang, Xinran; Eichholz, Jordan E; Mcpherson, Andrew; Thomas, Jasmine; Nagar, Karan; Rustgi, Naryan; Christin, John R; Kuo, Fengshen; Gao, Sizhi; Jiang, Hui; Luo, Jiaqian; Ostrovnaya, Irina; Basar, Merve; Pietzak, Eugene; Coleman, Jonathan A; Berger, Michael F; de Stanchina, Elisa; Shah, Sohrab P; Mohibullah, Neeman; Aggen, David H; Rosenberg, Jonathan E; Chandarlapaty, Sarat; Shen, Michael M; Al-Ahmadie, Hikmat; Iyer, Gopa; Kim, Kwanghee; Solit, David B

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.

调节 PPARγ 通路可上调 NECTIN4,并增强嵌合抗原受体 (CAR) T 细胞疗法在膀胱癌中的疗效

Chang Kevin, Delavan Henry M, Yip Elizabeth, Kasap Corynn, Zhu Jun, Lodha Roshan, Liao Sheng-You, Berman Sarah C, Carretero-Gonzalez Alberto, Basar Merve, Gokturk Ozcan Gamze, Teo Min Yuen, Solit David B, Rosenberg Jonathan E, Al-Ahmadie Hikmat, Ding Cornelia C K, Chan Emily, Steri Veronica, Porten Sima P, Koshkin Vadim S, Friedlander Terence W, Feng Felix Y, Lee John K, Wiita Arun P, Chu Carissa E, Chou Jonathan